Clariane Shares Drop 2% and Again Hit Resistance at €4.25
The personal services group's stock weakens at midday, going against the grain of a significantly bullish SBF 120. The decline brings the stock back to its short-term moving averages, after several weeks spent testing a resistance without being able to break through.
A Decline that Isolates the Stock in a Largely Bullish SBF 120
Clariane's stock loses 2.1% to €4.09, while the SBF 120 gains 0.77% and the CAC 40 advances by 0.75%. The stock is among the largest declines in the broad index, contrary to a Parisian market buoyed by the slowdown in inflation in the Eurozone (2.8% in June according to Eurostat, below consensus). Sodexo (+9.09%) and Carrefour (+3.89%) dominate the session on the upside. On other timelines, the stock sheds 1.59% over the week and remains nearly flat over a month (-0.1%), while it maintains a gain of 10.17% over three months. The annual decline still reaches 21.42%.
Testing Short-Term Moving Averages After Failing Below the €4.35 Resistance
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The price returns to the contact of the MM20 (€4.09) and the MM50 (€4.10), which it had been crossing upwards since mid-June. The MM200 at €3.94 remains 3.91% below the current price, preserving the medium-term orientation. The RSI at 56 exits the bullish zone without tipping into an oversold configuration. The identified support at €3.98 is the next technical milestone in case the decline continues. The movement of the day comes after several unsuccessful attempts at the €4.35 resistance, tested twice since mid-June. On the corporate front, the group launched a €333 million issuance of hybrid bonds on June 22 aimed at refinancing its ODIRNANE. The next financial milestone will be the publication of the semi-annual results, expected at the end of July according to the group's history.
SectorServices et infrastructure de santé›Etablissements de santé / EHPAD
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 2 699 millions d'euros
Quarterly revenue: 2 699 millions d'euros
Revenue growth: 1,6 %
EBITDA: 524 millions d'euros
EBITDA margin: 10,4 %
Net income: -47,5 millions d'euros
Free cash flow: 20 millions d'euros
3 020 millions d'euros
Guidance from the release
Le Groupe s'appuiera principalement sur la poursuite de l'amélioration de la performance opérationnelle et le maintien d'une stricte discipline d'investissements
Risks mentioned
Environnement géopolitique complexe affectant les opérations de refinancement
Exposition aux épisodes climatiques frappant durement certains territoires en Europe
Pression inflationniste continue sur les coûts opérationnels malgré les gains tarifaires
Opportunities identified
Amélioration de la marge EBITDA de 100-150 points de base d'ici fin 2026
Croissance des volumes d'activité portée par l'augmentation progressive des taux d'occupation
Refinancement réussi de €1 063m renforçant la flexibilité financière et réduisant le coût de la dette
Outlook / guidance
Expected revenue: 5 522 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.